During the opening ceremony of the BIO Asia-Taiwan Exhibition yesterday in Taipei, President Tsai Ing-wen (蔡英文) expressed the hope that advancements in Taiwan’s biotechnology industry would usher in major business opportunities from abroad, allowing the sector to reach NT$1 trillion (US$339.50 billion) in annual production.
Despite COVID-19, the annual biotech trade show attracted pharmaceutical and medical device companies from more than 500 nations, including the US, the UK, Australia, Switzerland and Malaysia.
The five-day exhibition is the first in-person international biotechnology trade show in Asia since the outbreak of COVID-19.
Photo: Chien Jung-fong, Taipei Times
Speaking at the opening ceremony, Tsai said that biotechnology is a crucial part of the “five plus two” innovative industries plan that she introduced during her first term, adding that she hopes the exhibition would be a platform for the nation to demonstrate innovativeness and accelerate the development of its biotech sector.
The nation would deregulate relevant laws to expedite the growth of the sector, she said.
The “five plus two” innovative industries plan refers to an initiative to develop an Asian equivalent of the US’ Silicon Valley, including biotech, green energy, industry 4.0, robotics, defense and aviation, as well as innovative agriculture and a circular economy.
Taiwan’s biomedical industry grew by 8.7 percent in annual revenue last year, a record high over the past few years, with the amount of capital invested reaching NT$55.1 billion, Tsai said, adding that digital medicine and precision medicine, two sectors that have shown great potential in recent years, are expected to grow significantly.
Cell therapy, regenerative medicine and genetic testing combined with big data analysis are also areas that have progressed a lot, while innovative medical devices, including nanomedical technology, are expected to receive more attention, she said.
New medicine development has also had breakthroughs, Tsai said, citing a licensing agreement signed in April by Taiwan’s Oneness Biotech Co Ltd and the Denmark-based Leo Pharma, a global leader in medical dermatology.
The agreement was signed to facilitate the development and introduction to the market of FB825, a drug candidate for novel atopic dermatitis and asthma, with an upfront payment to Oneness totaling US$530 million, the highest a Taiwanese company has ever received in such a deal.
Meanwhile, the National Biotechnology Research Park in collaboration with several multi-national pharmaceutical companies, accelerators and venture capital firms yesterday opened an accelerator hub for biomedical start-ups.
Speaking at the inauguration ceremony of the hub, former vice president Chen Chien-jen (陳建仁) said that the new facilities provide one-stop services to cultivate biomedical start-ups and has the potential to become the biggest accelerator hub in the field of biomedicine in the Asia-Pacific region.
The occupancy rate of biomedical companies at the park is 60 percent and the number is expected to reach 80 percent by the end of the year, Chen said, adding that growth at such a rate would be “beyond my imagination.”
Additional reporting by Chien Hui-ju
LOUD AND PROUD Taiwan might have taken a drubbing against Australia and Japan, but you might not know it from the enthusiasm and numbers of the fans Taiwan might not be expected to win the World Baseball Classic (WBC) but their fans are making their presence felt in Tokyo, with tens of thousands decked out in the team’s blue, blowing horns and singing songs. Taiwanese fans have packed out the Tokyo Dome for all three of their games so far and even threatened to drown out home team supporters when their team played Japan on Friday. They blew trumpets, chanted for their favorite players and had their own cheerleading squad who dance on a stage during the game. The team struggled to match that exuberance on the field, with
Taiwanese paleontologists have discovered fossil evidence that pythons up to 4m long inhabited Taiwan during the Pleistocene epoch, reporting their findings in the international scientific journal Historical Biology. National Taiwan University (NTU) Institute of Ecology and Evolutionary Biology associate professor Tsai Cheng-hsiu (蔡政修) led the team that discovered the largest snake fossil ever found in Taiwan. The single trunk vertebra was discovered in Tainan at the Chiting Formation, dated to between 400,000 and 800,000 years ago in the Middle Pleistocene, the paper said. The area also produced Taiwan’s first avian fossil, as well as crocodile, mammoth, saber-toothed cat and rhinoceros fossils, it said. Discoveries
Taiwanese paleontologists have discovered fossil evidence that pythons up to 4m long inhabited Taiwan during the Pleistocene epoch, reporting their findings in the international scientific journal Historical Biology. National Taiwan University (NTU) Institute of Ecology and Evolutionary Biology associate professor Tsai Cheng-hsiu (蔡政修) led the team that discovered the largest snake fossil ever found in Taiwan. A single trunk vertebra was discovered in Tainan at the Chiting Formation, dated to between 800,000 to 400,000 years ago in the Middle Pleistocene, the paper said. The area also produced Taiwan’s first avian fossil, as well as crocodile, mammoth, sabre-toothed cat and rhinoceros fossils, it said. Discoveries
Whether Japan would help defend Taiwan in case of a cross-strait conflict would depend on the US and the extent to which Japan would be allowed to act under the US-Japan Security Treaty, former Japanese minister of defense Satoshi Morimoto said. As China has not given up on the idea of invading Taiwan by force, to what extent Japan could support US military action would hinge on Washington’s intention and its negotiation with Tokyo, Morimoto said in an interview with the Liberty Times (sister paper of the Taipei Times) yesterday. There has to be sufficient mutual recognition of how Japan could provide
RSS